KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Accumulated Expenses (2016 - 2025)

Exact Sciences (EXAS) has disclosed Accumulated Expenses for 16 consecutive years, with $416.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 26.86% to $416.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $416.5 million, a 26.86% increase, with the full-year FY2025 number at $416.5 million, up 26.86% from a year prior.
  • Accumulated Expenses was $416.5 million for Q4 2025 at Exact Sciences, up from $408.8 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $416.5 million in Q4 2025 to a low of $214.1 million in Q1 2021.
  • A 5-year average of $315.3 million and a median of $308.1 million in 2022 define the central range for Accumulated Expenses.
  • Peak YoY movement for Accumulated Expenses: surged 90.67% in 2021, then tumbled 33.91% in 2023.
  • Exact Sciences' Accumulated Expenses stood at $398.6 million in 2021, then dropped by 24.92% to $299.2 million in 2022, then rose by 14.19% to $341.7 million in 2023, then decreased by 3.92% to $328.3 million in 2024, then grew by 26.86% to $416.5 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Accumulated Expenses are $416.5 million (Q4 2025), $408.8 million (Q3 2025), and $317.2 million (Q2 2025).